Cell MedX Corp. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q2 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Cell MedX Corp. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q2 2014 to Q2 2024.
  • Cell MedX Corp. Deferred Tax Assets, Valuation Allowance for the quarter ending May 31, 2024 was $1.88M, a 0.81% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $1.88M +$15K +0.81% May 31, 2024 10-K 2024-08-29
Q2 2023 $1.86M +$80K +4.49% May 31, 2023 10-K 2024-08-29
Q2 2022 $1.78M +$100K +5.95% May 31, 2022 10-K 2023-09-01
Q2 2021 $1.68M +$404K +31.6% May 31, 2021 10-K 2023-04-07
Q2 2020 $1.28M +$245K +23.7% May 31, 2020 10-K 2021-08-30
Q2 2019 $1.03M +$1.9M May 31, 2019 10-K 2020-09-15
Q2 2018 -$870K +$215K +19.8% May 31, 2018 10-K 2019-09-06
Q2 2017 -$1.09M -$384K -54.8% May 31, 2017 10-K 2018-09-13
Q2 2016 -$701K -$980K -351% May 31, 2016 10-K 2017-08-29
Q2 2015 $279K +$308K May 31, 2015 10-K 2016-09-13
Q2 2014 -$28.3K May 31, 2014 10-K 2015-09-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.